1. Home
  2. ICUCW vs GRABW Comparison

ICUCW vs GRABW Comparison

Compare ICUCW & GRABW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • GRABW
  • Stock Information
  • Founded
  • ICUCW N/A
  • GRABW 2012
  • Country
  • ICUCW United States
  • GRABW Singapore
  • Employees
  • ICUCW 18
  • GRABW 11267
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • GRABW Business Services
  • Sector
  • ICUCW Health Care
  • GRABW Consumer Discretionary
  • Exchange
  • ICUCW Nasdaq
  • GRABW Nasdaq
  • Market Cap
  • ICUCW N/A
  • GRABW N/A
  • IPO Year
  • ICUCW 2021
  • GRABW N/A
  • Fundamental
  • Price
  • ICUCW $0.05
  • GRABW $0.49
  • Analyst Decision
  • ICUCW
  • GRABW
  • Analyst Count
  • ICUCW 0
  • GRABW 0
  • Target Price
  • ICUCW N/A
  • GRABW N/A
  • AVG Volume (30 Days)
  • ICUCW N/A
  • GRABW 54.7K
  • Earning Date
  • ICUCW N/A
  • GRABW 02-21-2025
  • Dividend Yield
  • ICUCW N/A
  • GRABW N/A
  • EPS Growth
  • ICUCW N/A
  • GRABW N/A
  • EPS
  • ICUCW N/A
  • GRABW N/A
  • Revenue
  • ICUCW N/A
  • GRABW $2,686,000,000.00
  • Revenue This Year
  • ICUCW N/A
  • GRABW N/A
  • Revenue Next Year
  • ICUCW N/A
  • GRABW N/A
  • P/E Ratio
  • ICUCW N/A
  • GRABW N/A
  • Revenue Growth
  • ICUCW N/A
  • GRABW 21.65
  • 52 Week Low
  • ICUCW N/A
  • GRABW $0.15
  • 52 Week High
  • ICUCW N/A
  • GRABW $0.59
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW N/A
  • GRABW 66.31
  • Support Level
  • ICUCW N/A
  • GRABW $0.43
  • Resistance Level
  • ICUCW N/A
  • GRABW $0.55
  • Average True Range (ATR)
  • ICUCW 0.00
  • GRABW 0.05
  • MACD
  • ICUCW 0.00
  • GRABW 0.02
  • Stochastic Oscillator
  • ICUCW 0.00
  • GRABW 69.54

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About GRABW Grab Holdings Limited Warrant

Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

Share on Social Networks: